0 NYSE Companies - April 25, 2024HP’s Next Gen Antivirus Given Perfect Score In Independent TestPALO ALTO, Calif., April 25, 2024 (GLOBE NEWSWIRE) — A comprehensive new report from AV-TEST, a leading independent IT security […]Read More
0 NYSE Companies - April 25, 2024California Water Service Group’s First Quarter 2024 Financial Results Benefit from California 2021 General Rate Case DecisionSAN JOSE, Calif., April 25, 2024 (GLOBE NEWSWIRE) — California Water Service Group (“Group” or “Company,” NYSE: CWT), a leading […]Read More
0 NYSE Companies - April 25, 2024Diana Shipping Inc. Announces Time Charter Contract for m/v DSI Phoenix With Bulk Trading SAATHENS, Greece, April 25, 2024 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing […]Read More
0 NYSE Companies - April 25, 2024Verizon gives customers more peace of mind with enhanced Home Device Protection serviceNEW YORK, April 25, 2024 (GLOBE NEWSWIRE) — Research has shown that the average U.S. household has over $11,000 worth […]Read More
0 NYSE Companies - April 25, 2024Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings ResultsTARRYTOWN, N.Y., April 25, 2024 (GLOBE NEWSWIRE) — Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its […]Read More
0 NYSE Companies - April 25, 2024ArcelorMittal S.A.: ArcelorMittal announces the publication of its first quarter 2024 sell-side analyst consensus figures25 April 2024, 14:30 CET ArcelorMittal (‘the Company’) today announces the publication of its first quarter 2024 sell-side analyst consensus […]Read More
0 NYSE Companies - April 25, 2024Theriva™ Biologics to Discuss the Trial Design for VIRAGE – a Phase 2b Clinical Study of Systemically Administered VCN-01 in Combination with Chemotherapy in Pancreatic Ductal Adenocarcinoma – at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingROCKVILLE, Md., April 25, 2024 (GLOBE NEWSWIRE) — Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed […]Read More
0 NYSE Companies - April 25, 2024Theriva™ Biologics hablará sobre el diseño del ensayo VIRAGE, un estudio clínico de fase 2b de VCN-01 administrado sistémicamente en combinación con quimioterapia para el adenocarcinoma pancreático ductal, en la Reunión Anual de la Sociedad Americana de Oncología Clínica (ASCO) de 2024ROCKVILLE, Maryland, April 25, 2024 (GLOBE NEWSWIRE) — Theriva™ Biologics (NYSE American: TOVX), una empresa diversificada de fase clínica que […]Read More
0 NYSE Companies - April 25, 2024Enviri Corporation to Participate in Upcoming Investor ConferencesPHILADELPHIA, April 25, 2024 (GLOBE NEWSWIRE) — Enviri Corporation (NYSE: NVRI), a global, market-leading provider of environmental solutions for industrial […]Read More
0 NYSE Companies - April 25, 2024Integer Holdings Corporation Reports First Quarter 2024 Results~ Strong start to the year with 1Q24 financial results ~~ Reiterate 2024 financial outlook ~ PLANO, Texas, April 25, […]Read More